TABLE 1

Plasma epinephrine (pg/ml)

BasalAfter maze
Euglycemic
 Nondiabetic
  Control58 ± 4110 ± 20
  RH63 ± 3142 ± 32
 Diabetic
  Control51 ± 6160 ± 28
  RH49 ± 8124 ± 21
Hypoglycemic
 Nondiabetic
  Control65 ± 54,986 ± 539*
  RH75 ± 131,611 ± 363*
 Diabetic
  Control72 ± 73,010 ± 695*
  RH83 ± 12890 ± 293*
  • Plasma epinephrine concentrations, taken both at baseline (basal) and immediately after completion of maze testing.

  • *

    * Significant increase in after-maze versus basal samples;

  • significant effect of RH (epinephrine decreased versus controls);

  • significant effect of diabetes (epinephrine decreased versus nondiabetics).